Kevin Kotler, 10% Owner at NOVELION THERAPEUTICS INC. (NVLN), sold 533,246 shares at $0.87 ($483K) on 2018-12-26, disclosed to the SEC on 2018-12-27.
Open-market sale of $483k NVLN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.98 | 400 | $392 | 0.1% |
| 2 | $0.87 | 109,900 | $96K | 19.8% |
| 3 | $0.91 | 28,745 | $26K | 5.4% |
| 4 | $0.91 | 30,726 | $28K | 5.8% |
| 5 | $0.91 | 12,450 | $11K | 2.3% |
| 6 | $0.91 | 12,219 |
| $11K |
| 2.3% |
| 7 | $0.93 | 1,200 | $1K | 0.2% |
| 8 | $0.98 | 83,245 | $82K | 16.9% |
| 9 | $0.98 | 83,245 | $82K | 16.9% |
| 10 | $0.85 | 56,316 | $48K | 9.9% |
| 11 | $0.85 | 100,000 | $85K | 17.6% |
| 12 | $0.88 | 14,800 | $13K | 2.7% |
| Total | $0.91 avg | 533,246 | $483K | 100% |
| Filing → |
| BDSI | SELL | 2019-04-15 | $10.0M | — | Filing → |
| REPH | SELL | 2017-12-22 | $750K | — | Filing → |
| SSKN | SELL | 2016-03-14 | $348K | — | Filing → |